Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-24
1996-08-06
Northington Davis, Zinna
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142282, 5142328, 514253, 514365, 514397, 514374, 514434, 514435, 514452, 514453, 5142285, 544 60, 544150, 544378, 546197, 548146, 548215, 5483415, 548526, 548525, C07D23920, A61K 3136
Patent
active
055434274
ABSTRACT:
Novel carbamoyloxylabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure and treating cardiac failure utilizing compounds and compositions thereof are disclosed.
REFERENCES:
patent: 3361039 (1971-12-01), Andrews
patent: 4088659 (1978-05-01), Bhat et al.
patent: 4118508 (1978-10-01), Bhat et al.
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4564626 (1986-01-01), Kreutner et al.
patent: 4639443 (1987-01-01), Kosley et al.
patent: 4639446 (1987-01-01), Kosley
A. Laurenza, et al., Molecular Pharmacology, 32, 133 (1987).
CALBIOCHEM.RTM. Biochemical/Immunchemical Catalog, 1988 New Product Supplement, p,18.
Biologics, 13, (No. 4), Oct. 1987.
CALBIOCHEM.RTM. Biochemical/Immunochemical Catalog 1987, p. 102; S. P. Bartels et al., Current Eye Research, 2, 673 (Feb. 1983).
R. J. Cherill et al., Abtracts of Papers, 192nd ACS Naational Meeting, Medi, No. 48 (Sep. 1986).
J. Caprioli and M. Sears, The Yale Journal of Biology and Medicine, 57, 283 (1984).
K. B. Seamon and J. W. Daly, Trends in Pharmacological Sciences, 48, 120 (1983).
K. B. Seamon and J. W. Daly, J. Cyclic Nucleotide Research, 7, 201 (1981).
J. Caprioli, et al., Abstracts, Association for Research in Vision and Ophthalmology, 233 (1986-5:15).
S. P. Bartels, et al, Current Eye Research, 6, 307 (1987).
K. B. Seamon and J. W. Daly, in "Advances in Cyclic Nucleotide and Protein Phosphorylation Research", vol. 20, 1986, pp. 1 to 150.
N. J. de Souza, et al., Medicinal Research Reviews, 3, 201 (1983).
S. V. Bhat, et al., J. Med. Chem., 26, 486 (1983).
K. B. Seamon, et al., J. Med. Chem. 26 436 (1983).
S. V. Bhat, et al., Tetrahedron Letters, 1669 (1977).
S. V. Bhat, et al., J. C. S. Perkin I, 767 (1982).
J. Caprioli, et al., Investigative Ophthalmology and Visual Science, 25, 268 (1984).
J. Caprioli and M. Sears, The Lancet, 958 (1983).
K. B. Seamon, et al., Proc. Natl. Acad. Sci. USA, 78, 3363 (1981).
K. B. Seamon and J. W. Daly, The Journal of Biological Chemistry, 256, 9799 (1981).
J. Takeda, et al., The Journal of Investigative Dermatology, 81, 236 (1983).
J. Takeda, et al., The Journal of Investigative Dermatology, 81, 131 (1983).
H. Hzuka et al., Biochimica et Biophysica Acta., 444, 685 (1976).
H. Hzuka, et al., Biochimica et Biophysica Acta., 437, 150 (1976).
J. J. Voorhees, The Journal of Investigative Dermatology, 59, 114 (1972).
K. M. Halprin, et al., The Journal of Investigative Dermatology, 65, 170 (1975).
W. P. Raab, International Journal of Clinical Pharmacology, Therapy and Toxicology 18, 212 (1980).
Cherill Robert J.
Kosley, Jr. Raymond W.
O'Malley Gerard
Davis Zinna Northington
Hoechst-Roussel Pharmaceuticals Inc.
Wittekind Raymond R.
LandOfFree
Carbamoyloxylabdanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamoyloxylabdanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamoyloxylabdanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191307